These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 10884966)

  • 1. Preference-based measures in economic evaluation in health care.
    Neumann PJ; Goldie SJ; Weinstein MC
    Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods and issues associated with the use of quality-adjusted life-years.
    Revicki DA; Lenderking WR
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):105-14. PubMed ID: 22280200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
    Ungar WJ
    Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ordinal preference elicitation methods in health economics and health services research: using discrete choice experiments and ranking methods.
    Ali S; Ronaldson S
    Br Med Bull; 2012 Sep; 103(1):21-44. PubMed ID: 22859714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valuation of health-related quality of life and utilities in health economics].
    Greiner W; Klose K
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):120-5. PubMed ID: 24780709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating interventions in health: a reconciliatory approach.
    Wolff J; Edwards S; Richmond S; Orr S; Rees G
    Bioethics; 2012 Nov; 26(9):455-63. PubMed ID: 21535065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 12. Historical and methodological perspectives on cancer outcomes research.
    Mandelblatt JS; Eisenberg JM
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):23-32. PubMed ID: 8608053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient preferences and cost-utility analysis.
    Elnitsky CA; Stone P
    Appl Nurs Res; 2005 May; 18(2):74-6. PubMed ID: 15991103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 15. Health outcomes in economic evaluation: the QALY and utilities.
    Whitehead SJ; Ali S
    Br Med Bull; 2010; 96():5-21. PubMed ID: 21037243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting to changes in health: implications for cost-effectiveness analysis.
    Sharma R; Stano M; Haas M
    J Health Econ; 2004 Mar; 23(2):335-51. PubMed ID: 15019760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 19. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.